Can mRNA vaccines train the immune system to recognize and attack cancer? In this episode, we explore how mRNA cancer vaccines are designed, how they deliver tumor-specific instructions to immune cells, and why personalized neoantigen vaccines are gaining attention. We also cover current clinical progress, the potential to combine mRNA vaccines with immunotherapy, and the challenges that remain to be solved before these approaches become routine cancer treatments.
Podden och tillhörande omslagsbild på den här sidan tillhör
Vinod Reddy Lekkala. Innehållet i podden är skapat av Vinod Reddy Lekkala och inte av,
eller tillsammans med, Poddtoppen.
